CryoPort Inc (CYRX)

[stocktiger]

From the company

As most know we are waiting not for only the move to the OTC but the news that then will follow. An email from the company to someone who expressed their frustration with the long wait:

We certainly appreciate your frustration. But as I noted in my e-mail to you on Monday, our market maker has been adamant that we should not issue press releases or make other information available publicly until we are through the 15c211 process.

As an example as to why we have chosen this communication strategy, on April 23, 2007 we issued a press release concerning successful pilot shipments of Cryoport Express. The NASD responded with questions, comments and even wanted to talk to the customers involved to verify shipments specific to the press release, delaying the process.

We and our market maker believe we are in the final round of comments from the NASD, and hope to be able to provide positive news soon.

In addition, I can tell you that we continue to diligently execute our business plan to achieve our business objectives in a timely manner and as soon as we are clear on our 15c process we will immediately update our shareholders and investors.

Once again, we appreciate your patience.

Best regards,

Greg Burdick
Investor Relations
Cryoport Systems, Inc.